1.00 / AMA PRA Category 1 CreditTM 1.00 / CE for Nurses
Provided by Cleveland Clinic Foundation Center for Continuing Education and Cleveland Clinic Enterprise
The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of this activity from: Genentech, Inc.
Produced by Haymarket Medical Education
Rheumatoid arthritis (RA), an autoimmune disorder characterized by inflammation of the synovial joints and surrounding tissues, affects 1.5 million adults in the United States. The past decade has seen a tremendous amount of change in the field of RA: in addition to advances in treatment such as targeted therapies, a number of initiatives have been developed to improve the management of RA and quality of care. These include the latest guidelines and recommendations developed by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR), which support the identification of a therapeutic window and the desirability of tight disease control. As RA imposes a considerable burden on patients, their families, and society, therapeutic approaches call for early intervention with disease-modifying antirheumatic drugs (DMARDs), as either monotherapy or combination therapy, in order to avoid irreversible damage, long-term disability, and premature death. Numerous effective therapeutic options are now available, which facilitate individualization of treatment to optimize patient outcomes. This case depicts a patient diagnosed with RA who is no longer responding to methotrexate therapy; therefore, other DMARDs must be considered.
This activity is intended for rheumatologists and other healthcare professionals such as primary care physicians, internists, physician assistants, nurse practitioners, advanced practice nurses, and nurses who care for patients with rheumatoid arthritis.
At the conclusion of this activity, participants should be better able to:
Describe updates from the European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR) guidelines and apply appropriate new recommendations to clinical practice
Employ the “treat-to-target” approach to rheumatoid arthritis (RA) management via incorporation of routine use of validated composite disease-activity measures and instruments
Compare and contrast efficacy, safety, and tolerability of available biologic agents used in the presence of disease- and patient-related variables, such as risk tolerance and dosing convenience
Utilize effective communication and education to engage RA patients in shared decision-making on treatment choices
Conflict Of Interest Disclosure Policy
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
Stanley Cohen, MD Clinical Professor, Department of Internal Medicine University of Texas Southwestern Medical School Co-Director, Division of Rheumatology Presbyterian Hospital Dallas, TX
Dr. Cohen has indicated that he has a relationship, which in the context of his presentation, could be perceived as a potential conflict of interest:
AbbVie Pharmaceuticals: Membership on advisory committee or review panels
Elizabeth Kirchner, MSN Department of Rheumatic and Immunologic Diseases Cleveland Clinic Cleveland, OH
Ms. Kirchner has indicated that she has no relationships which, in the context of her presentation, could be perceived as a potential conflict of interest.
ACTIVITY DIRECTOR Leonard Calabrese, DO Professor of Medicine Cleveland Clinic, Lerner College of Medicine Case Western Reserve University R.J. Fasenmeyer Chair, Clinical Immunology Orthopaedic and Rheumatologic Institute Cleveland, OH
Dr. Calabrese has indicated that he has a relationship, which in the context of his presentation, could be perceived as a potential conflict of interest:
AbbVie Pharmaceuticals: Consulting, Teaching and Speaking BMS: Consulting, Teaching and Speaking Crescendo: Teaching and Speaking GSK: Consulting Genentech/Roche: Consulting, Teaching and Speaking Janssen: Consulting, Teaching and Speaking Pfizer: Consulting Sanofi-Aventis: Consulting UCB: Consulting
Accredited Provider Disclosure
The Cleveland Clinic Center for Continuing Education staff involved in the planning and content review of this activity have indicated they have no relationships that could be perceived as a potential conflict of interest.
Publishing Staff Disclosures
Haymarket Medical Education staff involved in the planning and content review of this activity have indicated they have no relationships that could be perceived as a potential conflict of interest.
AMA PRA Category 1 Credit(s)TM
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
Cleveland Clinic Enterprise is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1.00 contact hour.
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME/CE activity are those of the authors/faculty. They do not represent an endorsement by Cleveland Clinic or Haymarket Medical Education. In no event will Cleveland Clinic Foundation or Haymarket Medical Education be liable for any decision made or action taken in reliance upon the information provided through this CME/CE activity.
If you have any questions relating to the accreditation of this activity, please contact Cleveland Clinic at 216-444-9990.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.